Duexis
NDC Package 75987-010-72

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Duexis is this combination medication is used to relieve pain from rheumatoid arthritis and osteoarthritis while decreasing the risk of developing an ulcer from ibuprofen use. Marketed by Horizon Therapeutics Usa, Inc., this product is identified by NDC 75987-010 and is authorized under FDA application NDA022519.

Identification & Billing

NDC Package Code
75987-010-72
Package Description
9 BLISTER PACK in 1 CARTON / 3 TABLET, COATED in 1 BLISTER PACK
Product Code
75987-010
11-Digit Billing Format
75987001072

Clinical Specifications

Proprietary Name
Duexis
Dosage Form
-
Usage Information
This combination medication is used to relieve pain from rheumatoid arthritis and osteoarthritis while decreasing the risk of developing an ulcer from ibuprofen use. It contains ibuprofen and famotidine. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that works by blocking your body's production of certain natural substances that cause inflammation. This helps to decrease swelling and pain. Famotidine is an H2 blocker that works by reducing the amount of acid in your stomach. This helps prevent ulcers. Ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section.

Regulatory & Marketing

Labeler Name
Horizon Therapeutics Usa, Inc.
FDA Application #
NDA022519
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-05-2011
End Marketing Date
08-31-2025
Listing Expiration
08-31-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (75987-010). Click a package code to view its specific billing and regulatory data.

75987-010-03
90 TABLET, COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 75987-010-72 identifies a specific commercial package of 9 blister pack in 1 carton / 3 tablet, coated in 1 blister pack of Duexis, labeled by Horizon Therapeutics Usa, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Horizon Therapeutics Usa, Inc. on December 05, 2011. The current certification is valid through August 31, 2025.

What are the primary indications for this medication?

This combination medication is used to relieve pain from rheumatoid arthritis and osteoarthritis while decreasing the risk of developing an ulcer from ibuprofen use. It contains ibuprofen and famotidine. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that works by blocking your body's production of certain natural substances that cause inflammation. This helps to decrease swelling and pain. Famotidine is an H2 blocker that works by reducing the amount of acid in your stomach. This helps prevent ulcers. Ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section.

How is this Horizon Therapeutics Usa, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 75987001072. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
75987-010-72
11-Digit CMS (5-4-2)
75987-0010-72

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.